Kinkead E R, Bunger S K, Wolfe R E, Flemming C D, Whitmire R E, Wall H G
NSI Technology Services Corporation/Mantech Environmental Technology, Inc., Dayton, Ohio 45431-0009.
Toxicol Ind Health. 1991 Jul;7(4):295-307. doi: 10.1177/074823379100700405.
C8 polychlorotrifluoroethylene (pCTFE) oligomers accumulate preferentially in the liver during long-term oral exposure and appear to be more hepatotoxic than C6 oligomers. A repeated-dose gavage study was initiated to determine the relative contributions of the corresponding C6 (trimer) and C8 (tetramer) acid metabolites to the toxicity of pCTFE in the male Fischer 344 rat. Test animals were dosed once per week for various time periods up to one year. A depression (p less than 0.05) in mean body weight occurred in the highest dose tetramer acid (2.16 mg/kg) group. An increase in hepatic peroxisomal beta-oxidation activity was found in the 2.16 mg pCTFE tetramer acid/kg dose group at the 3-, 6-, and 9-month sacrifice periods. An increase in relative liver weight was seen at all sacrifice periods in this dose group. Hepatocellular cytomegaly was a common finding in the higher dose tetramer acid groups but not in the trimer-treated rat groups.
在长期口服暴露期间,八氯三氟乙烯(pCTFE)低聚物优先在肝脏中蓄积,并且似乎比六氯三氟乙烯低聚物的肝毒性更强。开展了一项重复剂量灌胃研究,以确定相应的六氯三氟乙烯(三聚体)和八氯三氟乙烯(四聚体)酸代谢物对雄性Fischer 344大鼠pCTFE毒性的相对贡献。对实验动物每周给药一次,持续不同时间段直至一年。最高剂量的四聚体酸(2.16毫克/千克)组出现平均体重下降(p<0.05)。在3个月、6个月和9个月处死期时,在2.16毫克pCTFE四聚体酸/千克剂量组中发现肝脏过氧化物酶体β-氧化活性增加。在该剂量组的所有处死期均可见相对肝脏重量增加。肝细胞肿大在高剂量四聚体酸组中是常见现象,但在三聚体处理的大鼠组中未出现。